克利夫兰生物实验室(CBLI.US)盘前大涨18.76%,报5.76美元。公司与美国细胞通信公司Cytocom宣布合并登记声明和委托声明。 网页链接
$克利夫兰生物实验室(CBLI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-017944 Size: 13 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-017946 Size: 13 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-017947 Size: 13 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-017948 Size: 13 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-017949 Size: 13 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-017950 Size: 5 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-017951 Size: 5 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-017952 Size: 5 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K Current report, items 2.01, 5.01, 5.02, 5.03, 8.01, and 9.01 Accession Number: 0001437749-21-017701 Act: 34 Size: 636 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 内部交易: 2021-07-22,Chief Medical Officer,Miller Langdon L ,期权,10000普通股, $3.00